NCT05111015 Tracking Results of Ablations to Combat AF Registry Generation 2
| NCT ID | NCT05111015 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AtriCure, Inc. |
| Condition | Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2024-03-11 |
| Primary Completion | 2040-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2024-03-11 with a primary completion date of 2040-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.
Eligibility Criteria
Inclusion Criteria: 1. Patient has been scheduled by physician(s) to undergo or has undergone cardiac ablation procedure(s) 2. Patient is willing to provide informed consent 3. Patient whose age is 18 years or above, or of legal age to give informed consent specific to state and national law Exclusion Criteria: 1\. Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05111015 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05111015 currently recruiting?
Yes, NCT05111015 is actively recruiting participants. Contact the research team at jgoodarz@atricure.com for enrollment information.
Where is the NCT05111015 trial being conducted?
This trial is being conducted at Huntsville, United States, Jonesboro, United States, Little Rock, United States, Loma Linda, United States and 11 additional locations.
Who is sponsoring the NCT05111015 clinical trial?
NCT05111015 is sponsored by AtriCure, Inc.. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.